Quotient Sciences Quotient Sciences

X

Find Drugs in Development News & Deals for Menthol

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
17
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Details:

Crampsal Cream (pain relieving oils) is a non-greasy pain relief cream with mixture of pain-relieving oils, menthol & camphor. It penetrates deep into the skin and provides long lasting relief.


Lead Product(s): Menthol,Camphor

Therapeutic Area: Neurology Product Name: Crampsal

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Senta Pharma

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 29, 2021

Octavius Pharma

BePharma 2024

Not Confirmed

envelop Contact Supplier

Details:

The Company intends to use the net proceeds from the Offering to fund the Company's pre-investigational new drug meeting with the United States FDA regarding the human application and expansion of the Company's derma-cosmetic product distribution.


Lead Product(s): Cannabidiol,Menthol,Camphor

Therapeutic Area: Neurology Product Name: Relief & Go

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Research Capital Corporation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Private Placement October 12, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
  • Deals

Details:

The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence.


Lead Product(s): Camphor,Capsicum oleoresin,Menthol

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Angelini Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition March 10, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY